chr5-1266524-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000310581.10(TERT):c.2594G>A(p.Arg865His) variant causes a missense change. The variant allele was found at a frequency of 0.00000311 in 1,609,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R865C) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000310581.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.2594G>A | p.Arg865His | missense_variant | 10/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.2594G>A | p.Arg865His | missense_variant | 10/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.2491G>A | non_coding_transcript_exon_variant | 8/13 | ||||
TERT | NR_149163.3 | n.2455G>A | non_coding_transcript_exon_variant | 8/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERT | ENST00000310581.10 | c.2594G>A | p.Arg865His | missense_variant | 10/16 | 1 | NM_198253.3 | ENSP00000309572 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000823 AC: 2AN: 242928Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131302
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1457526Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 724390
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74336
ClinVar
Submissions by phenotype
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2007 | - - |
Likely pathogenic, criteria provided, single submitter | research | Garcia Pulmonary Genetics Research Laboratory, Columbia University Irving Medical Center | May 19, 2022 | - - |
Interstitial lung disease 2 Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | case-control | Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | May 06, 2018 | - - |
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 865 of the TERT protein (p.Arg865His). This variant is present in population databases (rs121918666, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of TERT-related conditions (PMID: 17460043, 22853774, 28102861, 30523342). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12736). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TERT protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TERT function (PMID: 17460043, 20022961, 22364217, 23901009, 25365545). For these reasons, this variant has been classified as Pathogenic. - |
Dyskeratosis congenita, autosomal dominant 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 17, 2023 | - - |
Pulmonary fibrosis Pathogenic:1
Likely risk allele, no assertion criteria provided | research | Garcia Pulmonary Genetics Research Laboratory, Columbia University Irving Medical Center | Jun 09, 2022 | Leukocyte telomere length (by qPCR) less than 10th percentile age-adjusted - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 18, 2017 | The R865H variant has been published previously in association with TERT-related disorders (Tsakiri et al., 2007; Fernandez et al., 2012; DiNardo et al., 2016). The variant is observed in 1/23030 (0.004%) alleles from individuals of African background in the ExAC dataset (Lek et al., 2016). This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, functional studies have demonstrated that R865H results in significantly reduced enzyme activities (Tsakiri et al., 2007; Zaug et al., 2013). In summary, we consider this variant to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at